For Patients
Learn About Our Clinical Trials
Oncternal is committed to advancing our pipeline and bringing patients a new wave of novel cancer therapies. Clinical trials are an important part of that process. Both Oncternal-sponsored and investigator sponsored clinical trials are ongoing to understand the potential therapeutic benefit our product candidates might provide, to help researchers understand how to best use them, and determine the best path to ultimately gain regulatory approval.
ONCT-808
Zilovertamab
Consolidation for Treatment of Patients with Detectable CLL on Venetoclax (NCT04501939)